CLOCK expression levels are higher in more aggressive ERα-positive compared to ERα-negative breast tumours and estrogen promotes the binding of ERα to estrogen-response elements in the CLOCK promoter [54]. The gene discussed is CLOCK; the disease is breast neoplasm.